{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:44:51Z","timestamp":1776987891403,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jcv.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T12:45:36Z","timestamp":1478868336000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Ebola virus disease: An update on current prevention and management strategies"],"prefix":"10.1016","volume":"86","author":[{"given":"M.A.","family":"Trad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mazlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"O\u2019sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcv.2016.11.005_bib0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00705-013-1846-9","article-title":"Discussions and decisions of the 2012\u20132014 international committee on the taxonomy of viruses (ICTV) filoviridae study group, January 2012\u2013June 2013","volume":"159","author":"Bukreyev","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jcv.2016.11.005_bib0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2016.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of zaire ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0020","doi-asserted-by":"crossref","unstructured":"G.M. Lyon, A.K. Mehta, J.B. Varkey, K. Brantly, L. Plyler, A.K. McElroy, et al. Clinical Care of Two Patients with Ebola Virus Disease in the United States November 12, (epub ahead of print) 2014. doi: 10.1056\/nejmoa1409838.","DOI":"10.1056\/NEJMoa1409838"},{"key":"10.1016\/j.jcv.2016.11.005_bib0025","unstructured":"http:\/\/www.cdc.gov\/vhf\/ebola\/treatment\/ Last accessed on 5\/10\/2016."},{"issue":"9957","key":"10.1016\/j.jcv.2016.11.005_bib0030","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(14)62043-2","article-title":"First trials for Ebola treatments announced","volume":"384","author":"Mohammadi","year":"2014","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.jcv.2016.11.005_bib0035","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2016.11.005_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7774\/cevr.2015.4.1.11","article-title":"Progress of vaccine and drug development for Ebola preparedness","volume":"4","author":"Choi","year":"2015","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"4","key":"10.1016\/j.jcv.2016.11.005_bib0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14760584.2014.885841","article-title":"Ebola virus vaccines: and overview of current approaches","volume":"13","author":"Marzi","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jcv.2016.11.005_bib0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2016.11.005_bib0055","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"NEJM"},{"issue":"April","key":"10.1016\/j.jcv.2016.11.005_bib0060","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine\u2014preliminary report","author":"Regules","year":"2015","journal-title":"NEJM"},{"key":"10.1016\/j.jcv.2016.11.005_bib0065","doi-asserted-by":"crossref","DOI":"10.1038\/nature14428","article-title":"Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus","author":"Mire","year":"2015","journal-title":"Nature"},{"issue":"158","key":"10.1016\/j.jcv.2016.11.005_bib0070","doi-asserted-by":"crossref","first-page":"158ra146","DOI":"10.1126\/scitranslmed.3004582","article-title":"Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates","volume":"4","author":"Wong","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.jcv.2016.11.005_bib0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralising antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"Mast","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2016.11.005_bib0080","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"Zhu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2016.11.005_bib0085","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMp0708117","article-title":"One step forward, two steps back\u2014will there ever be an AIDS vaccine","volume":"357","author":"Steinbrook","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0090","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrd4398","article-title":"HIV vaccine failure due to induction of immune suppressors?","author":"Flamming","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jcv.2016.11.005_bib0095","doi-asserted-by":"crossref","first-page":"h1307","DOI":"10.1136\/bmj.h1307","article-title":"Ebola vaccines based on adenovirus vectors and risk of HIV","volume":"350","author":"Kremer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2016.11.005_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"Lu","year":"2008","journal-title":"Expert Rev. Vaccines"},{"issue":"17","key":"10.1016\/j.jcv.2016.11.005_bib0105","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA","volume":"374","author":"Ewer","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jcv.2016.11.005_bib0110","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2015.1995","article-title":"Emergency postexposure vaccination with vesicular stomatitis virus-vectored ebola vaccine after needlestick","volume":"313","author":"Lai","year":"2015","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2016.11.005_bib0115","doi-asserted-by":"crossref","first-page":"S785","DOI":"10.1093\/infdis\/jir298","article-title":"Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany","volume":"204","author":"G\u00fcnther","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.11.005_bib0120","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2015.03.029","article-title":"A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose","volume":"33","author":"Tsuda","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jcv.2016.11.005_bib0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/14787210.2015.1028368","article-title":"A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact","volume":"13","author":"Jonsson-Scmunk","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2016.11.005_bib0130","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment: of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.11.005_bib0135","first-page":"997","article-title":"Ebola virus disease in Southern Sudan: hospital dissemination and intrafamilial spread","volume":"61","author":"Baron","year":"1983","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jcv.2016.11.005_bib0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in Guinea","volume":"374","author":"Van Grienswen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virusres.2015.12.019","article-title":"Specific neutralizing response in plasma from convalescent petients of Ebola virus disease against the West Africa Makona variant of Ebola virus","volume":"213","author":"Luczkowiak","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2016.11.005_bib0150","doi-asserted-by":"crossref","first-page":"199ra113","DOI":"10.1126\/scitranslmed.3006608","article-title":"Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail","volume":"5","author":"Pettitt","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0155","first-page":"1138ra81","article-title":"Successful treatment: of ebola virus\u2013infected cynomolgus macaques with monoclonal antibodies","author":"Qiu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0160","doi-asserted-by":"crossref","first-page":"207ra143","DOI":"10.1126\/scitranslmed.3006605","article-title":"MAbs and ad-vectored IFN-a therapy rescue ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"Qiu","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0165","first-page":"9","article-title":"Effective binding of a phosphatidylserine-targeting antibody to ebola virus infected cells and purified virions","author":"Dowall","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jcv.2016.11.005_bib0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.jcv.2016.11.005_bib0175","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment: with favipiravir for ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0180","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(15)60232-X","article-title":"Favipiravir for children with Ebola","volume":"385","author":"Bouazza","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2016.11.005_bib0185","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"issue":"September (9)","key":"10.1016\/j.jcv.2016.11.005_bib0190","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"issue":"October (10)","key":"10.1016\/j.jcv.2016.11.005_bib0195","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","article-title":"Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses","volume":"12","author":"Florescu","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.jcv.2016.11.005_bib0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jcv.2016.11.005_bib0205","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/civ395","article-title":"Administration of Brincidofovir and convalescent plasma in a patient with Ebola virus disease","volume":"61","author":"Florescu","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"December","key":"10.1016\/j.jcv.2016.11.005_bib0210","first-page":"62384","article-title":"Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care","author":"Wolf","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcv.2016.11.005_bib0215","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.1.21003","article-title":"First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain,S eptember to November 2014","volume":"20","author":"L\u00f3paz","year":"2015","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2016.11.005_bib0220","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"issue":"October (10)","key":"10.1016\/j.jcv.2016.11.005_bib0225","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0230","unstructured":"N. Thomas, Novavax Study to evaluate the immunogenicity and safety of an Ebola virus glycoprotein vaccine in healthy subjects. In: ClinicalTrials.gov [internet] Bethesda (MD): National Library of Medicine (US). 2000- [cited 2016 Jun 8]. Available from: http:\/\/clinicaltrials.gov\/show\/NCT02370589. NLM Study identifier: NCT02370589."},{"issue":"13","key":"10.1016\/j.jcv.2016.11.005_bib0235","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"PNAS"},{"issue":"October (44)","key":"10.1016\/j.jcv.2016.11.005_bib0240","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2016.11.005_bib0245","unstructured":"Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments http:\/\/www.niaid.nih.gov\/news\/newsreleases\/2015\/Pages\/ZMapp.aspx (accessed 27.02.15)."},{"issue":"2","key":"10.1016\/j.jcv.2016.11.005_bib0250","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody mediated neutralization of ebola virus can occur by 2 distinct mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2016.11.005_bib0255","unstructured":"http:\/\/hfv.lanl.gov\/content\/sequence\/HFV\/ToolsOutline.html (accessed 04.03.16)."},{"issue":"1","key":"10.1016\/j.jcv.2016.11.005_bib0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effects of Artesunate-Amodiaquine on mortality related to Ebola virus disease","volume":"374","author":"Gignoux","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcv.2016.11.005_bib0265","doi-asserted-by":"crossref","first-page":"e1001815","DOI":"10.1371\/journal.pmed.1001815","article-title":"Evaluating clinical trial designs for investigational treatments of ebola virus disease","volume":"12","author":"Cooper","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.jcv.2016.11.005_bib0270","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12879-015-1169-4","article-title":"Ebola virus disease complicated with viral interstitial pneumonia: a case report","volume":"15","author":"Petrosillo","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"108","key":"10.1016\/j.jcv.2016.11.005_bib0275","article-title":"Pre-symptomatic diagnosis and treatment of filovirus diseases","volume":"6","author":"Shurtleff","year":"2015","journal-title":"Front Microbiol."},{"issue":"4","key":"10.1016\/j.jcv.2016.11.005_bib0280","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2016.11.005_bib0285","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/cid\/civ420","article-title":"Supportive care of the first 2 Ebola virus disease patients at the monrovia medical unit","volume":"61","author":"Wong","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.11.005_bib0290","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.15-0461","article-title":"Case report a health care worker with Ebola virus disease and adverse prognostic factors treated in Sierra Leone","author":"O\u2019shea","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"December (6)","key":"10.1016\/j.jcv.2016.11.005_bib0295","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.accpm.2015.06.010","article-title":"Fluid resuscitation in Ebola Virus Disease: a comparison of peripheral and central venous accesses","volume":"34","author":"Cotte","year":"2015","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"8","key":"10.1016\/j.jcv.2016.11.005_bib0300","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/S2214-109X(15)00065-0","article-title":"Health-care worker mortality and the legacy of the Ebola epidemic","volume":"3","author":"Evans","year":"2015","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jcv.2016.11.005_bib0305","unstructured":"http:\/\/www.nbcdfw.com\/news\/health\/Ebola-Patient-Dr-Kent-Brantly-to-Leave-Hospital-Thursday-272102161.html (Last accessed 06.07.16)."},{"key":"10.1016\/j.jcv.2016.11.005_bib0310","article-title":"Ebola virus disease complications as experienced by survivors in Sierra Leone","volume":"21","author":"Tiffany","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"May","key":"10.1016\/j.jcv.2016.11.005_bib0315","article-title":"New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors","author":"Sow","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.11.005_bib0320","unstructured":"www.who.int\/csr\/research-and-development\/blueprint\/en (Last accessed on 03.10.16)."},{"key":"10.1016\/j.jcv.2016.11.005_bib0325","unstructured":"www.who.int\/csr\/resources\/publications\/ebola\/report-by-panel.pdf?ua=1 (Last accessed 03.10.16)."},{"issue":"21","key":"10.1016\/j.jcv.2016.11.005_bib0330","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","article-title":"Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies","volume":"89","author":"Davidson","year":"2015","journal-title":"J. Virol."},{"issue":"December (22)","key":"10.1016\/j.jcv.2016.11.005_bib0335","doi-asserted-by":"crossref","first-page":"14013","DOI":"10.1093\/nar\/gku1209","article-title":"Structural basis for inhibition of DNA replication by aphidicolin","volume":"42","author":"Baranovskiy","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665321630590X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665321630590X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T10:08:00Z","timestamp":1568542080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665321630590X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":67,"alternative-id":["S138665321630590X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.11.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebola virus disease: An update on current prevention and management strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}